Kestrel BioSciences is now part of Lumos Diagnostics.
Lumos develops custom-built, point-of-care solutions for its customers using a unique combination of assay and engineering capability paired with its proven reader technologies. Lumos recently acquired Kestrel BioSciences to strengthen its assay development and test strip manufacturing capability.
Lumos has specific expertise in developing assays across a range of POC, chemistry and technology platforms. These can be configured as stand-alone, manual-read products or interfaced with Lumos readers or third-party hardware for fully automated solutions.
Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. Our reader platforms act as a starting point to reduce overall product development effort and timeline. They are easily customizable to meet partner and/or end user needs and price points.
Cloud & Data
Lumos has developed a digital cloud platform that enables our clients to leverage the cloud to create an entire product ecosystem that enhances reader capability. We work collaboratively with you to customize our platform and develop a specific solution that fits your exact needs.
Reach out to Lumos today to understand how we can deliver you a customized point-of-care diagnostic solution.